Shares of the pharmaceutical company climb to a new peak as its proposed entry into finished-dose drug development and US regulatory filings draws attention amid a broader market sell-off.

Rising crude oil prices, persistent foreign investor outflows, concerns over interest rates, limited liquidity and cautious positioning ahead of a long weekend combined to pressure Indian equities.

Persistent foreign investor selling, elevated crude oil prices and rising US bond yields weighed on Indian equities, while domestic institutions continued buying. PB Fintech and Maruti Suzuki faced additional company-specific concerns.

Organ donation can offer a life-saving treatment to people suffering from organ failure, but the process is governed by legal, medical and ethical safeguards designed to protect donors and recipients.

Household liabilities climbed to $1.59 trillion, outpacing asset accumulation; deposits remained the largest component of financial portfolios even as insurance, pensions and securities recorded growth.

Monthly UPI volume slips to 24.07 billion from August’s record, but daily activity reaches new highs as festive spending supports digital payments.

Ambit’s Nitin Bhasin expects moderate Nifty returns over the next 12 months, sees elevated valuations, foreign-investor caution, crude volatility and a heavy supply of new equity as key market challenges.

Commercial LPG rises to ₹2,810 per 19-kg cylinder in Delhi while ATF climbs to ₹137 per litre; household LPG, petrol and diesel prices remain unchanged

Package includes eight nuclear reactors, a Texas gas-fired power project and a proposed Alaska LNG development, but Seoul says the Alaska investment is not yet final.